SCHEMBL9111053

SCHEMBL9111053

CC(N)C(N)CCC(N)C(C)N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.38
TRPA1 O75762 1/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
OPRM1 P35372 1/20 0.33
CYP2D6 P10635 1/20 0.32
SPHK1 Q9NYA1 1/20 0.32
GABRP O00591 2/20 0.30
GABRD O14764 2/20 0.30
GABRA1 P14867 2/20 0.30
GABRB1 P18505 2/20 0.30
GABRG2 P18507 2/20 0.30
GABRB3 P28472 2/20 0.30
GABRA5 P31644 2/20 0.30
GABRA3 P34903 2/20 0.30
GABRA2 P47869 2/20 0.30
GABRB2 P47870 2/20 0.30
GABRA4 P48169 2/20 0.30
GABRE P78334 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9401873 0.96 TRPV1 (0.36) TRPV1TRPA1ALDH1A1TSHRMAPK1
SCHEMBL16541330 0.89 OPRM1 (0.41) TRPV1TRPA1ALDH1A1TSHRMAPK1
SCHEMBL10704437 0.89 TRPV1 (0.33) TRPV1TRPA1ALDH1A1
SCHEMBL9180639 0.85 TRPV1 (0.41) TRPV1TRPA1ALDH1A1TSHRMAPK1
SCHEMBL3020246 0.82
SCHEMBL648050 0.82
SCHEMBL14923929 0.82
SCHEMBL613349 0.79
SCHEMBL22129328 0.79
SCHEMBL28841721 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0512724-A2 Acidic palladium strike bath AT&T Corp. (US) 1992-11-11 EP claimed
WO-1995008539-A1 IMPROVED METHODS FOR PREPARING BIS-IMIDE COMPOUNDS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-03-30 WO disclosed
US-5329048-A Reaction of tert-butyloxycarbonylaniline with 1,1' carbonyl diimidazole then ethylenediamine, then acidification to remove tert-butyloxycarbonyl THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1994-07-12 US disclosed
US-5206249-A Diastereoisomers; enantiomorphs; antitumor agents DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-04-27 US disclosed